Ryan P. Westergaard

5.7k total citations
101 papers, 1.9k citations indexed

About

Ryan P. Westergaard is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Ryan P. Westergaard has authored 101 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 37 papers in Infectious Diseases and 21 papers in General Health Professions. Recurrent topics in Ryan P. Westergaard's work include HIV, Drug Use, Sexual Risk (43 papers), HIV/AIDS Research and Interventions (30 papers) and Opioid Use Disorder Treatment (18 papers). Ryan P. Westergaard is often cited by papers focused on HIV, Drug Use, Sexual Risk (43 papers), HIV/AIDS Research and Interventions (30 papers) and Opioid Use Disorder Treatment (18 papers). Ryan P. Westergaard collaborates with scholars based in United States, United Kingdom and Malaysia. Ryan P. Westergaard's co-authors include Gregory D. Kirk, Shruti H. Mehta, Timothy Flanigan, Anne C. Spaulding, Elizabeth A. Jacobs, Shawnika J. Hull, Karli R. Hochstatter, Joshua A. Barocas, John Fangman and William J. Ehlenbach and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Social Science & Medicine.

In The Last Decade

Ryan P. Westergaard

91 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan P. Westergaard United States 27 878 830 451 274 255 101 1.9k
Victoria Sharp United States 26 612 0.7× 794 1.0× 734 1.6× 240 0.9× 137 0.5× 64 1.8k
Jacqueline P. Tulsky United States 26 1.0k 1.2× 1.1k 1.3× 820 1.8× 256 0.9× 384 1.5× 58 2.1k
Bertrand Lebouché Canada 26 826 0.9× 645 0.8× 304 0.7× 171 0.6× 128 0.5× 142 1.9k
Raquel B. De Boni Brazil 23 798 0.9× 827 1.0× 395 0.9× 209 0.8× 335 1.3× 109 1.9k
Cheng‐Shiun Leu United States 26 537 0.6× 1.4k 1.7× 1.1k 2.5× 392 1.4× 300 1.2× 133 2.5k
Carol Bova United States 23 414 0.5× 564 0.7× 693 1.5× 329 1.2× 255 1.0× 60 2.3k
Peter L. Flom United States 25 860 1.0× 438 0.5× 428 0.9× 286 1.0× 284 1.1× 60 1.8k
Joseph Cox Canada 27 1.5k 1.7× 1.1k 1.3× 597 1.3× 239 0.9× 321 1.3× 183 2.5k
Keming Rou China 23 1.2k 1.3× 956 1.2× 404 0.9× 278 1.0× 448 1.8× 70 1.7k
Ali Mirzazadeh Iran 29 1.7k 1.9× 1.2k 1.4× 627 1.4× 408 1.5× 698 2.7× 194 3.0k

Countries citing papers authored by Ryan P. Westergaard

Since Specialization
Citations

This map shows the geographic impact of Ryan P. Westergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan P. Westergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan P. Westergaard more than expected).

Fields of papers citing papers by Ryan P. Westergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan P. Westergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan P. Westergaard. The network helps show where Ryan P. Westergaard may publish in the future.

Co-authorship network of co-authors of Ryan P. Westergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan P. Westergaard. A scholar is included among the top collaborators of Ryan P. Westergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan P. Westergaard. Ryan P. Westergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morenz, Anna M., Robin M. Nance, Judith Feinberg, et al.. (2025). Barriers to accessing medications for opioid use disorder among rural individuals. International Journal of Drug Policy. 140. 104805–104805. 4 indexed citations
2.
Dague, Laura, et al.. (2025). Continuity of Prescription Medication Use Among Adults Leaving State Prison. JAMA Network Open. 8(2). e2461982–e2461982.
3.
Tully, Damien C., Karen A. Power, Thomas J. Stopka, et al.. (2024). Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance. Journal of Viral Hepatitis. 31(5). 266–270. 1 indexed citations
4.
Whitney, Bridget M., Wiley D. Jenkins, Thomas J. Stopka, et al.. (2024). Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances. PubMed. 18. 3337205814–3337205814.
5.
6.
Kline, David, William C. Miller, Judith Feinberg, et al.. (2024). Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduction Journal. 21(1). 214–214.
7.
Kaya, Cahit, et al.. (2024). Health and Social Service Needs of People who Inject Drugs Living in Rural Settings in the United States: A Qualitative Study. Health Behavior and Policy Review. 11(1). 1 indexed citations
8.
Afshar, Majid, Askar Safipour Afshar, Joseph Cavanaugh, et al.. (2023). Creation of a data commons for substance misuse related health research through privacy-preserving patient record linkage between hospitals and state agencies. JAMIA Open. 6(4). ooad092–ooad092. 4 indexed citations
9.
Miller, William C., David Kline, Bridget M. Whitney, et al.. (2023). Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. International Journal of Drug Policy. 141. 104222–104222. 4 indexed citations
10.
Moreno, Gage K., Katarina M. Braun, Ian W. Pray, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing. Clinical Infectious Diseases. 73(Supplement_1). S45–S53. 19 indexed citations
11.
Hochstatter, Karli R., David H. Gustafson, Gina Landucci, et al.. (2021). Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial. JMIR mhealth and uhealth. 9(2). e23080–e23080. 13 indexed citations
12.
Dawson, Patrick, Elizabeth M. Rabold, Rebecca L. Laws, et al.. (2020). Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019. Clinical Infectious Diseases. 72(4). 682–685. 81 indexed citations
13.
Hochstatter, Karli R., Klaren Pe‐Romashko, David H. Gustafson, et al.. (2020). Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention. AIDS and Behavior. 25(2). 354–359. 93 indexed citations
14.
Hochstatter, Karli R., Shawnika J. Hull, Ajay K. Sethi, et al.. (2020). Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial. Journal of Medical Internet Research. 22(9). e19703–e19703. 6 indexed citations
15.
Hochstatter, Karli R., David H. Gustafson, Gina Landucci, et al.. (2019). A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 8(8). e12620–e12620. 7 indexed citations
16.
Westergaard, Ryan P., Karli R. Hochstatter, Danielle Kahn, et al.. (2019). Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study. AIDS and Behavior. 23(9). 2549–2557. 11 indexed citations
17.
Sun, Shufang, et al.. (2018). Re-entry experiences of Black men living with HIV/AIDS after release from prison: Intersectionality and implications for care. Social Science & Medicine. 211. 78–86. 28 indexed citations
18.
Hochstatter, Karli R., Shawnika J. Hull, Lauren J. Stockman, et al.. (2017). Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. International Journal of Drug Policy. 42. 22–25. 7 indexed citations
19.
20.
Linas, Beth, et al.. (2016). Ecological Momentary Assessment of Illicit Drug Use Compared to Biological and Self-Reported Methods. JMIR mhealth and uhealth. 4(1). e27–e27. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Sharp Breakdown of academic impact, for papers by Jacqueline P. Tulsky Breakdown of academic impact, for papers by Bertrand Lebouché Breakdown of academic impact, for papers by Raquel B. De Boni Breakdown of academic impact, for papers by Cheng‐Shiun Leu Breakdown of academic impact, for papers by Carol Bova Breakdown of academic impact, for papers by Peter L. Flom Breakdown of academic impact, for papers by Joseph Cox Breakdown of academic impact, for papers by Keming Rou Breakdown of academic impact, for papers by Ali Mirzazadeh
Rankless by CCL
2026